{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-04-01",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Terminated",
      "city": "Corona",
      "state": "CA",
      "country": "United States",
      "classification": "Class III",
      "openfda": {},
      "product_type": "Drugs",
      "event_id": "74316",
      "recalling_firm": "Aidarex Pharmaceuticals LLC",
      "address_1": "595 N Smith Ave Ste B",
      "address_2": "N/A",
      "postal_code": "92880-6920",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "FAX",
      "distribution_pattern": "IN, GA",
      "recall_number": "D-0974-2016",
      "product_description": "CEFTRIAXONE for Injection USP, 250mg/vial, Rx only, MFG: LUPIN LIMITED INDIA, Packaged by Aidarex Pharmaceuticals, NDC 53217-0117-01",
      "product_quantity": "10",
      "reason_for_recall": "CGMP Deviations: Out of specification (OOS) intermediate in the subsequent processes to manufacture the final API.",
      "recall_initiation_date": "20160601",
      "center_classification_date": "20160607",
      "termination_date": "20161014",
      "report_date": "20160615",
      "code_info": "Lot#: 47312-1, Exp 01/2018"
    }
  ]
}